Atlas Trials

Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fed Conditions

Clinical trial NCT01367626 · COMPLETED

Trial details

NCT number
NCT01367626
Sponsor
Roxane Laboratories
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Breast Cancer
Start date
2008-03-01
Primary completion
2008-04-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.